EQL Pharma Investor Relations Material
EQL Pharma AB engages in the development, marketing, and sale of specialty and generic medicines to pharmacies and hospitals in Europe. It specializes in the treatment of male infertility by proactive production and sale of medicines under its owned trademarks to end consumers, private actors as well as public hospitals and pharmacies. The company was founded in 2006 and is based in Lund, Sweden
Upcoming events for
Q2 22/232022-11-11
Q1 22/232022-08-16
Latest company events
Ticker symbol
EQL
Country
Sweden
About the company
Investor Relations Page
Dig deeper into the EQL Pharma fundamentals on Quartr.
- Skip straight to the Q&A session
- Receive notifications about new events
- Connect the financial calender on your phone
- Figure out why the stock is up or down
- Read the transcripts or scroll the deck
- Access earnings or press releases
